Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry

References

Page 1

	Year	Citations
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge William T. Friedewald, Robert I. Levy, Donald S. Fredrickson Clinical Chemistry Lipid AnalysisHyperlipidemiaDirect ProcedureMetabolic SyndromeBody Composition	1972	32.1K
Metformin and reduced risk of cancer in diabetic patients Josie Evans, Louise A. Donnelly, Alistair Emslie‐Smith, BMJ	2005	2.3K
Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease Yingchun Ma, Li Zuo, Jianghua Chen, Journal of the American Society of Nephrology Glomerular DiseaseHypertensionMetabolic SyndromeRenal FunctionBody Composition	2006	1.9K
New Users of Metformin Are at Low Risk of Incident Cancer Gillian Libby, Louise A. Donnelly, Peter T. Donnan, Diabetes Care	2009	981
Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin Samantha L. Bowker, Sumit R. Majumdar, Paul J. Veugelers, Diabetes Care	2006	925
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Jessica A. Davila, Robert O. Morgan, Yasser H. Shaib, Gut	2005	697
Diabetes Mellitus and the Risk of Cancer Manami Inoue Archives of Internal Medicine	2006	563
Prospective Study of Hyperglycemia and Cancer Risk Pär Stattin, Ove Björ, Pietro Ferrari, Diabetes Care	2007	347
Sulphonylureas and cancer: a case–control study Matteo Monami, Caterina Lamanna, Daniela Balzi, Acta Diabetologica Case–control StudyMedicinePathologyOncologyMalignant Disease	2008	190
Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men Carmen Rodríguez American Journal of Epidemiology Epidemiology Of CancerDiabetes EpidemiologyOncologyIncident Prostate CancerPublic Health	2005	183

Page 1